Constitutive overexpression of cyclin D1 in human breast epithelial cells does not prevent G1 arrest induced by deprivation of epidermal growth factor

被引:37
作者
Chou, JL
Fan, Z
DeBlasio, T
Koff, A
Rosen, N
Mendelsohn, J
机构
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
关键词
cyclin D-1; EGF deprivation; G(1) arrest;
D O I
10.1023/A:1006217413089
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Non-transformed human breast epithelial cell line MCF10A is dependent on exogenous epidermal growth factor (EGF) for continued growth. Complete G(1) arrest was rapidly induced following EGF deprivation. The cell cycle arrest was accompanied by increased levels of p27(KIP1), a cyclin-dependent kinase inhibitor, and reduced level of cyclin D-1. This was associated with strong inhibition of cyclin-dependent kinase 2 and cyclin D-1-associated kinase activities. Introduction of exogenous cyclin D-1 into MCF10A (MCF10AD1) cells resulted in an accelerated cell growth rate but did not confer colony-forming capacity. Cell cycle arrest was still achieved in MCF10AD1 cells following EGF deprivation. In the great majority of MCF10AD1 clones, accumulation in G(1) phase was accompanied by reduced cyclin D-1 and increased p27(KIP1) protein levels. In two clones where cyclin D-1 remained unchanged during G(1) arrest, it was found that more cyclin D-1 protein was bound to p27(KIP1). The data demonstrate that ectopic expression of cyclin D-1 alone could not transform MCF10A cells nor was it sufficient to prevent G(1) arrest induced by EGF deprivation.
引用
收藏
页码:267 / 283
页数:17
相关论文
共 73 条
[1]   Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27(KIP1) [J].
Aktas, H ;
Cai, H ;
Cooper, GM .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (07) :3850-3857
[2]   BLOCKADE OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR INHIBITS TRANSFORMING GROWTH-FACTOR ALPHA-INDUCED BUT NOT ESTROGEN-INDUCED GROWTH OF HORMONE-DEPENDENT HUMAN-BREAST CANCER [J].
ARTEAGA, CL ;
CORONADO, E ;
OSBORNE, CK .
MOLECULAR ENDOCRINOLOGY, 1988, 2 (11) :1064-1069
[3]  
ATLAS I, 1992, CANCER RES, V52, P3335
[4]   ANTITUMOR EFFECTS OF DOXORUBICIN IN COMBINATION WITH ANTIEPIDERMAL GROWTH-FACTOR RECEPTOR MONOCLONAL-ANTIBODIES [J].
BASELGA, J ;
NORTON, L ;
MASUI, H ;
PANDIELLA, A ;
COPLAN, K ;
MILLER, WH ;
MENDELSOHN, J .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (16) :1327-1333
[5]  
BERENSON JR, 1989, ONCOGENE, V4, P1111
[6]  
BUCKLEY MF, 1993, ONCOGENE, V8, P2127
[7]  
CALLENDER T, 1994, CANCER-AM CANCER SOC, V74, P152, DOI 10.1002/1097-0142(19940701)74:1<152::AID-CNCR2820740124>3.0.CO
[8]  
2-K
[9]   Regulation of cyclin D1 by calpain protease [J].
Choi, YH ;
Lee, SJ ;
Nguyen, P ;
Jang, JS ;
Lee, J ;
Wu, ML ;
Takano, E ;
Maki, M ;
Henkart, PA ;
Trepel, JB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (45) :28479-28484
[10]  
CHOU JL, 1989, CANCER RES, V49, P5371